A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Varghese, Kucku ^a,b   Molnar, Peter ^a   Das, Mainak ^a   Bhargava, Neelima ^a   Lambert, Stephen ^a,c   Kindy, Mark S ^b   Hickman, James J ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; HIPPOCAMPUS; MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; PATCH CLAMP; POTASSIUM CURRENT; RAT; SYNAPSE; ACTION POTENTIAL; ANIMAL; CYTOLOGY; DRUG EFFECT; METHODOLOGY; PHYSIOLOGY; VALIDATION STUDY;

ACTION POTENTIALS; AMYLOID BETA-PROTEIN; ANIMALS; CURCUMIN; HIPPOCAMPUS; PATCH-CLAMP TECHNIQUES; RATS; SYNAPSES;

EID: 77649091582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008643     Document Type: Article

References (45)

1. Klein WL (2002) A beta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochemistry International 41(5): 345-352.
2. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America 95(11): 6448-6453.
3. St George-Hyslop PH, Petit A (2005) Molecular biology and genetics of Alzheimer's disease. Comptes Rendus Biologies 328(2): 119-130.
4. Townsend KP, Pratico D (2005) Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. Faseb Journal 19(12): 1592-1601.
5. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16(5): 921-932.
6. Hardy J, Selkoe DJ (2002) Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297(5580): 353-356.
7. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008) Amyloid-[beta] protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nature Medicine 14(8): 837-842.
8. Knobloch M, Mansuy IM (2008) Dendritic spine loss and synaptic alterations in Alzheimer's disease. Molecular Neurobiology 37(1): 73-82.
9. Lacor PN (2007) Advances on the understanding of the origins of synaptic pathology in AD. Current Genomics 8(8): 486-508.
10. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, et al. (2007) Neurobiology of Disease Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease. Journal of Neuroscience Methods 27(4): 796-807.
11. Walsh DM, Selkoe DJ (2007) Aβ Oligomers - a decade of discovery Journal of Neurochemistry 101: 1172-1184.
12. Francis PT (2008) Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease. Neurodegenerative Diseases 5(3-4): 241-243.
13. Koike T, Yang Y, Suzuki K, Zheng X (2008) Axon & dendrite degeneration: its mechanisms and protective experimental paradigms. Neurochem Internat 52(4-5): 751-760.
14. Waataja JJ, Kim HJ, Roloff AM, Thayer SA (2008) Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death ournal of Neurochemistry 104(2): 364-375.
15. Hua JY, Smith SJ (2004) Neural activity and the dynamics of central nervous system development. Nature Neuroscience 7: 327-332.
16. Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, et al. (2008) Amyloid β oligomers (A β (1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents Journal of Neuroscience Methods 28(4): 788-797.
17. Hamaguchi T, Ono K, Yamada M (2006) Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease. Cellular and Molecular Life Sciences 63(13): 1538-1552.
18. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989) Scavenging Effect of Extracts of Green Tea and Natural Antioxidants on Active Oxygen Radicals. Cell Biophysics 14(2): 175-185.
19. Lim GP, Chu T, Yang FS, Beech W, Frautschy SA, et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience 21(21): 8370-8377.
20. Yang FS, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 280(7): 5892-5901.
21. Gureviciene I, Ikonen S, Gureviclus K, Sarkaki A, van Groen T, et al. (2004) Normal induction but accelerated decay of LTP in APP+PS1 transgenic mice. Neurobiology of Disease 15(2): 188-195.
22. Jhamandas JH, Cho C, Jassar B, Harris K, MacTavish D, et al. (2001) Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. Journal of Neurophysiology 86(3): 1312-1320.
23. Egert U, Schlosshauer B, Fennrich S, Nisch W, Fejtl M, et al. (1998) A novel organotypic long-term culture of the rat hippocampus on substrate-integrated multielectrode arrays. Brain Research Protocols 2(4): 229-242.
24. Jung DR, Cuttino DS, Pancrazio JJ, Manos P, Cluster T, et al. (1998) Cell-based sensor microelectrode array characterized by imaging x-ray photoelectron spectroscopy, scanning electron microscopy, impedance measurements, and extracellular recordings. Journal of Vacuum Science & Technology a-Vacuum Surfaces and Films 16(3): 1183-1188.
25. Natarajan A, Molnar P, Sieverdes K, Jamshidi A, Hickman JJ (2006) Microelectrode array recordings of cardiac action potentials as a high throughput method to evaluate pesticide toxicity. Toxicology in Vitro 20(3): 375-381.
26. Offenhausser A, Sprossler C, Matsuzawa M, Knoll W (1997) Field-effect transistor array for monitoring electrical activity from mammalian neurons in culture. Biosensors & Bioelectronics 12(8): 819-826.
27. Nam Y, Wheeler BC, Heuschkel MO (2006) Neural recording adn stimulation of dissociated hippocampal cultures using microfabricated three-dimensional tip electrode array. Journal of Neuroscience Methods 155(2): 296-299.
28. Hofmann F, Bading H (2006) Long term recordings with microelectrode arrays: Studies of transcription-dependent neuronal plasticity and axonal regeneration. Journal of Physiology-Paris 99(2-3): 125-132.
29. Thomas CA, Springer PA, Okun LM, Berwaldn Y, Loeb GE (1972) Miniature Microelectrode Array to Monitor Bioelectric Activity of Cultured Cells. Experimental Cell Research 74(1): 61-&.
30. Gross GW, Gramowski A, Schiffmann D (1997) Neural network cultures on multielectrode chips: Self-organization of electrically active networks and their uses in neurotoxicology and neuropharmacology. European Journal of Cell Biology 74: 36-36.
31. Meyer T, Boven KH, Gunther E, Fejtl M (2004) Micro-electrode arrays in cardiac safety pharmacology - A novel tool to study QT interval prolongation. Drug Safety 27(11): 763-772.
32. Chang JC, Brewer GJ, Wheeler BC (2001) Modulation of neural network activity by patterning. Biosensors & Bioelectronics 16(7-8): 527-533.
33. Golan H, Mikenberg K, Greenberger V, Segal M (2000) GABA withdrawal modifies network activity in cultured hippocampal neurons. Neural Plasticity 7(1-2): 31-42.
34. Gross GW, Rhoades BK, Azzazy HME, Wu MC (1995) The Use of Neuronal Networks on Multielectrode Arrays as Biosensors. Biosensors & Bioelectronics 10(6-7): 553-567.
35. Gramowski A, Jugelt K, Stuwe S, Schulze R, McGregor GP, et al. (2006) Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips. European Journal of Neuroscience 24(2): 455-465.
36. Keefer EW, Norton SJ, Boyle NAJ, Talesa V, Gross GW (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology 22(1): 3-12.
37. Parviz M, Gross GW (2007) Quantification of zinc toxicity using neuronal networks on microelectrode arrays. Neurotoxicology 28(3): 520-531.
38. Chen QS, Kagan BL, Hirakura Y, Xie CW (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. Journal of Neuroscience Research 60(1): 65-72.
39. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, et al. (2002) Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Research 924(2): 133-140.
40. Ahuja TK, Mielke JG, Comas T, Chakravarthy B, Mealing GAR (2007) Hippocampal slice cultures integrated with multi-electrode arrays: A model for study of long-term drug effects on synaptic activity. Drug Development Research 68(2): 84-93.
41. Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nature Reviews Drug Discovery 5(2): 160-170.
42. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, et al. (1992) Beta-Amyloid Peptides Destabilize Calcium Homeostasis and Render Human Cortical-Neurons Vulnerable to Excitotoxicity. Journal of Neuroscience 12(2): 376-389.
43. Schaffner AE, Barker JL, Stenger DA, Hickman JJ (1995) Investigation of the factors necessary for growth of hippocampal neurons in a defined system. Journal of Neuroscience Methods 62(1-2): 111-119.
44. Das M, Molnar P, Devaraj H, Poeta M, Hickman JJ (2003) Electrophysiological and morphological characterization of rat embryonic motoneurons in a defined system. Biotechnology Progress 19(6): 1756-1761.
45. Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized Survival of Hippocampal-Neurons in B27-Supplemented Neurobasal(Tm), a New Serum-Free Medium Combination. Journal of Neuroscience Research 35(5): 567-576.